BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Skyline Medical Announces Two Proposed Joint Ventures and New Strategic Focus on CRO Services

  New collaborations with Helomics and CytoBioscience to diversify Skyline’s operations into the rapidly growing CRO Services sector.

  November 8, 2017

   · 

  8 min read
• Business

  SYGNIS AG Reports Financial Results for the Third Quarter and First Nine Months of 2017

  Revenues increased 4-fold to € 5.3M for the first nine months of 2017 through a combination of organic and acquisitive growth.

  November 8, 2017

   · 

  8 min read
• Business

  Lipocine Announces Financial and Operational Results for the Third Quarter and Nine Months Ended September 30, 2017

  Lipocine reported a net loss of $4.7 million, or ($0.22) per diluted share, for the third quarter ended September 30, 2017.

  November 8, 2017

   · 

  8 min read
• Genetown

  SeraCare Announces Industry’s First Comprehensive NGS Reference Material for Hematologic Malignancies

  To help clinical labs performing NGS-based myeloid testing thoroughly understand and characterize their assays, SeraCare has developed the Seraseq Myeloid Mutation DNA Mix and Seraseq Myeloid Fusion RNA Mix.

  November 8, 2017

   · 

  4 min read
• Business

  Epigenomics AG: Appointment of Director Reimbursement and Medical Affairs

  Epigenomics AG announced today that Nicholas T. Potter, PhD, FACMG has accepted the role of Director of Reimbursement and Medical Affairs effective November 1, 2017.

  November 8, 2017

   · 

  3 min read
• Business

  Neuralstem Strengthens Executive Leadership Team With Appointment of Dr. David Recker as Chief Medical Officer

  Dr. David Recker is the founding manager of JJK Consulting, a group that advises on pharmaceutical development.

  November 8, 2017

   · 

  3 min read
• Business

  Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  The company reported a net loss of $22.9 million, or $0.53 per share (basic and diluted), for the third quarter of 2017 compared to a net loss of $30.3 million.

  November 8, 2017

   · 

  11 min read
• Biognosys Announces a Technological Breakthrough in the Development of Its Next-Generation Proteomics Workflow

  Biognosys announced today a breakthrough in the development of its next generation proteomics technology that helps scientists to understand complex biological processes.

  November 8, 2017

   · 

  3 min read
• Business

  Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance

  Total revenue for the fourth quarter of fiscal 2017 was $20.1 million, as compared with $18.2 million in the prior-year period.

  November 8, 2017

   · 

  14 min read
• Business

  ArcherDX, Celgene Ink Worldwide Companion Diagnostic Agreement Relating to Investigational Drug CC-122

  Under the terms of the agreement, ArcherDX will use their patented Anchored Multiplex PCR technology combined with the Illumina MiSeqDx sequencing system and Archer Analysis bioinformatics software to develop the CDx.

  November 8, 2017

   · 

  1 min read